Ardelyx Inc (ARDX)
8.465
-0.82
(-8.78%)
USD |
NASDAQ |
May 08, 16:00
8.45
-0.02
(-0.18%)
After-Hours: 18:49
Ardelyx Cash from Financing (Quarterly): 52.97M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 52.97M |
| December 31, 2023 | 25.99M |
| September 30, 2023 | 57.87M |
| June 30, 2023 | 11.52M |
| March 31, 2023 | 50.92M |
| December 31, 2022 | 18.79M |
| September 30, 2022 | 34.48M |
| June 30, 2022 | 22.14M |
| March 31, 2022 | -0.063M |
| December 31, 2021 | 14.51M |
| September 30, 2021 | 4.999M |
| June 30, 2021 | 28.72M |
| March 31, 2021 | 34.77M |
| December 31, 2020 | 21.18M |
| September 30, 2020 | 0.798M |
| June 30, 2020 | 0.204M |
| March 31, 2020 | 0.591M |
| December 31, 2019 | 155.06M |
| September 30, 2019 | 0.213M |
| June 30, 2019 | 0.005M |
| March 31, 2019 | 0.20M |
| December 31, 2018 | -0.001M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.191M |
| June 30, 2018 | 103.06M |
| March 31, 2018 | 0.301M |
| December 31, 2017 | 0.01M |
| September 30, 2017 | 0.251M |
| June 30, 2017 | 0.016M |
| March 31, 2017 | 0.408M |
| December 31, 2016 | 0.214M |
| September 30, 2016 | 109.68M |
| June 30, 2016 | 0.188M |
| March 31, 2016 | 81.12M |
| December 31, 2015 | 0.014M |
| September 30, 2015 | -0.003M |
| June 30, 2015 | 74.70M |
| March 31, 2015 | 0.296M |
| December 31, 2014 | 0.066M |
| September 30, 2014 | 0.003M |
| June 30, 2014 | 61.24M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.001M |
| June 30, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.063M
Minimum
Mar 2022
155.06M
Maximum
Dec 2019
26.78M
Average
19.98M
Median
Cash from Financing (Quarterly) Benchmarks
| Nektar Therapeutics | 0.012M |
| Rigel Pharmaceuticals Inc | 0.486M |
| Omeros Corp | -104.95M |
| Vistagen Therapeutics Inc | 93.52M |
| Karyopharm Therapeutics Inc | 0.264M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.72M |
| Cash from Investing (Quarterly) | -2.572M |
| Free Cash Flow | -81.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1539 |
| Free Cash Flow to Equity (Quarterly) | -85.88M |
| Free Cash Flow to Firm (Quarterly) | -31.80M |
| Free Cash Flow Yield | -4.22% |